# Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast Cancer

> **NCT02183805** · PHASE2 · TERMINATED · sponsor: **Sun Yat-sen University** · enrollment: 6 (actual)

## Conditions studied

- Carcinoma Breast Stage IV

## Interventions

- **DRUG:** Abraxane,Cyclophosphamide,Carboplatin

## Key facts

- **NCT ID:** NCT02183805
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-06-17
- **Primary completion:** 2020-12-15
- **Final completion:** 2020-12-15
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Difficulty accruing subjects the study accrual was closed
- **Last updated:** 2021-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02183805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02183805, "Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02183805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*